Heartbeam (NASDAQ: BEAT) — Perfil da empresa, notícias e dados financeiros
Heartbeam innovates in heart disease management with advanced ECG solutions aimed at improving detection and monitoring.
Heartbeam
Heartbeam (NASDAQ:BEAT) is a pioneering company focused on revolutionizing the management of heart disease through its innovative technology. Specializing in the development of advanced electrocardiogram (ECG) solutions, Heartbeam aims to make significant strides in detecting and monitoring heart conditions in a more accurate and efficient manner. Their projects are geared towards leveraging telemedicine and mobile health applications, aiming to provide patients and healthcare providers with critical, real-time cardiac data. Heartbeam's objective is centered around improving patient outcomes and reducing healthcare costs by facilitating early detection of heart issues, thus paving the way for prompt and effective treatment. With its commitment to innovation, Heartbeam is dedicated to leading the charge in transforming cardiac care for people around the globe.
Resumo
Operações
Produtos e/ou serviços de Heartbeam
- A breakthrough ECG software technology designed to precisely detect heart attacks using a combination of standard and novel ECG leads.
- A portable, credit card-sized device enabling real-time, 12-lead ECG recording and heart attack detection.
- A cloud-based platform providing secure, real-time analysis and reporting of ECG data for prompt diagnosis.
- A telemedicine service facilitating remote cardiac monitoring and consultations, improving access to cardiac care.
- An advanced algorithm for detecting subtle signs of ischemia in ECG signals, enhancing early diagnosis.
- A research partnership focused on integrating AI with ECG technology to predict and prevent cardiac events.
equipe executiva do Heartbeam
- Richard M. FerrariExecutive Chairman
- Branislav VajdicFounder, President & Director
- Timothy CruickshankChief Financial Officer
- Kenneth PersenChief System Development Officer
- Peter J. FitzgeraldMember of Scientific Advisory Board & Chief Medical Advisor
- Richa GujaratiSenior Vice President of Product
- Lance MyersChief Artificial Intelligence Scientist
- Bryan HumbargerChief Commercial Officer
Últimas notícias sobre a Heartbeam
Principais indicadores financeiros
Resultados divulgados pela Heartbeam, em USD.
- Cap. de mercado
- 30 mi
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -0.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -21,1 mi | -21 mi | |
| 0 | -19,9 mi | -19,4 mi | |
| 0 | -15,3 mi | -14,6 mi | |
| 0 | -13 mi | -12,8 mi |